Deciphera fills in where Blueprint falls short with early FDA nod in rare stomach cancer aliu Mon, 05/18/2020 – 11:34 More: Deciphera fills in where Blueprint falls short with early FDA nod in rare stomach cancer Source: fierce
read moreTeva bails on price-fixing settlement in gamble on its role fighting COVID-19: report kblankenship Mon, 05/18/2020 – 10:25 More: Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report Source: fierce
read moreFiercePharmaPolitics—COVID-19 brings divisions on hydroxychloroquine, reopening esagonowsky Mon, 05/18/2020 – 10:15 More: FiercePharmaPolitics—COVID-19 brings divisions on hydroxychloroquine, reopening Source: fierce
read moreMore threat to Gilead’s HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada aliu Mon, 05/18/2020 – 10:06 More: More threat to Gilead's HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada Source: fierce
read moreThe guidelines should help healthcare professionals decide what care to provide for people without COVID-19 infection or with confirmed or suspected infection safely while making the best use of NHS resources More: New COVID-10 guidelines for CKD and interstitial lung
read moreViiV said cabotegravir was found to be 69% more effective at preventing HIV acquisition than daily oral PrEP with emtricitabine/tenofovir disoproxil (FTC/TDF) More: ViiV HIV prevention trial stopped early on efficacy Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals